MycoWorks create materials at the intersection of art, nature and biotechnology using mycelium, one of the earth’s most regenerative resources. Their first product, Reishi offers partners in fashion an option for leather that is neither animal nor plastic, yet uncompromising in quality and aesthetic expression. The company was founded in 2013 by Philip Ross and Sophia Wang and is headquartered in San Francisco, CA.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
10/18/2022 | Series C-2 | $37.05MM | $xx.xx | $517.12MM | GM Ventures, SOSV | |
Price per Share
$xx.xx
Shares Outstanding
8,509,417
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
GM Ventures, SOSV
|
||||||
01/13/2022 | Series C | $126.25MM | $xx.xx | $455.29MM | Prime Movers Lab, SK Networks, Mirabaud Lifestyle Impact & Innovation Fund, DCVC Bio, Novo Holdings | |
Price per Share
$xx.xx
Shares Outstanding
31,970,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Prime Movers Lab, SK Networks, Mirabaud Lifestyle Impact & Innovation Fund, DCVC Bio, Novo Holdings
|
||||||
11/17/2020 | Series B-2 | $5MM | $xx.xx | $136.2MM | WTT Investment Ltd., DCVC Bio, Valor Equity Partners, Humboldt Fund, Gruss & Co., Novo Holdings, 8VC, SOSV, AgFunder, Wireframe Ventures, Tony Fadell, Natalie Portman, John Legend | |
Price per Share
$xx.xx
Shares Outstanding
3,776,079
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
WTT Investment Ltd., DCVC Bio, Valor Equity Partners, Humboldt Fund, Gruss & Co., Novo Holdings, 8VC, SOSV, AgFunder, Wireframe Ventures, Tony Fadell, Natalie Portman, John Legend
|
||||||
11/17/2020 | Series B-1 | $45MM | $xx.xx | $136.2MM | WTT Investment Ltd., DCVC Bio, Valor Equity Partners, Humboldt Fund, Gruss & Co., Novo Holdings, 8VC, SOSV, AgFunder, Wireframe Ventures, Tony Fadell, Natalie Portman, John Legend | |
Price per Share
$xx.xx
Shares Outstanding
25,490,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
WTT Investment Ltd., DCVC Bio, Valor Equity Partners, Humboldt Fund, Gruss & Co., Novo Holdings, 8VC, SOSV, AgFunder, Wireframe Ventures, Tony Fadell, Natalie Portman, John Legend
|
||||||
05/08/2019 | Series A-3 | $623,858 | $xx.xx | $29.56MM | DCVC Bio, Novo Holdings, 8VC, Future Tech Labs, AgFunder, Susa Ventures, Cthulhu Ventures, Wireframe Ventures | |
Price per Share
$xx.xx
Shares Outstanding
1,001,378
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
DCVC Bio, Novo Holdings, 8VC, Future Tech Labs, AgFunder, Susa Ventures, Cthulhu Ventures, Wireframe Ventures
|
||||||
05/08/2019 | Series A-2 | $1.84MM | $xx.xx | $29.56MM | DCVC Bio, Novo Holdings, 8VC, Future Tech Labs, AgFunder, Susa Ventures, Cthulhu Ventures, Wireframe Ventures | |
Price per Share
$xx.xx
Shares Outstanding
4,176,623
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
DCVC Bio, Novo Holdings, 8VC, Future Tech Labs, AgFunder, Susa Ventures, Cthulhu Ventures, Wireframe Ventures
|
||||||
05/08/2019 | Series A-1 | $154,478 | $xx.xx | $29.56MM | DCVC Bio, Novo Holdings, 8VC, Future Tech Labs, AgFunder, Susa Ventures, Cthulhu Ventures, Wireframe Ventures | |
Price per Share
$xx.xx
Shares Outstanding
1,180,129
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
DCVC Bio, Novo Holdings, 8VC, Future Tech Labs, AgFunder, Susa Ventures, Cthulhu Ventures, Wireframe Ventures
|
||||||
05/08/2019 | Series A | $11.31MM | $xx.xx | $29.56MM | DCVC Bio, Novo Holdings, 8VC, Future Tech Labs, AgFunder, Susa Ventures, Cthulhu Ventures, Wireframe Ventures | |
Price per Share
$xx.xx
Shares Outstanding
14,521,047
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
DCVC Bio, Novo Holdings, 8VC, Future Tech Labs, AgFunder, Susa Ventures, Cthulhu Ventures, Wireframe Ventures
|